Saturday 17 October 2026 Export HSIC’s income statement to Excel — free account

Henry Schein, Inc.

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

86.38 0.61 −0.70%

Follow HSIC

Alert me

Market cap: $9.7B
P/E: 25.0×
Fwd P/E: 18.5×
Dividend yield: —
F-score: 5/9
Altman Z: 2.66
Beneish M: −2.51
Dividend safety: 69/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total buys 0.69

Total sells 8.35

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	1	—	—	—	—	—
Sell	—	—	—	1	4	—	—	—	—	—	—	—

Insider Ownership 17.05%

Capital & Financial Ratios $m

Market Cap 9,690.00

Revenue 13,602.00

Net Income 426.00

Free Cash Flow 569.00

Net Debt 2,281.00

Current Ratio 1.32

Debt/Equity 0.64

P/E ratio 24.97

Fwd P/E 18.50

P/S ratio 0.72

P/B ratio 2.57

Past 5Y EPS Growth 3.01%

This Y EPS Growth 8.47%

Next Y EPS Growth 11.18%

Next Y revenue growth 5.11%

Next 5Y EPS Growth 9.92%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 90.31%

10-year low 10-year high

P/S against its own 10 years 19.94%

10-year low 10-year high

P/B against its own 10 years 45.34%

10-year low 10-year high

EV/Sales against its own 10 years 30.70%

10-year low 10-year high

EV/FCF against its own 10 years 70.36%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	171	122	156	157
Receivables	1,863	1,482	1,651	1,763
Inventory	1,815	1,810	2,002	2,059
Other	—	—	—	—
	4,488	3,983	4,464	4,600

	2023	2024	2025	Q'26
Payables	1,020	962	1,154	1,135
ST’ Debt	150	56	33	138
Other	—	—	—	—
	2,683	2,803	3,228	3,488

Compound Annual Growth %

	10y	5y	3y
Sales	2.18%	5.43%	1.40%
Cash Flow	1.47%	3.52%	5.75%
Earnings	(1.84%)	(0.30%)	(9.56%)
Book Value	3.05%	(0.43%)	(1.62%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	3,368	3,458	—	—	—
’25	3,168	3,240	3,339	3,437	13,184
’24	3,172	3,136	3,174	3,191	12,673
’23	3,060	3,100	3,162	3,017	12,339
’22	3,179	3,030	3,067	3,371	12,647
’21	2,925	2,967	3,178	3,331	12,401
’20	2,429	1,684	2,840	3,166	10,119

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(97)	242	—	—	—
’25	37	120	174	381	712
’24	197	296	151	204	848
’23	27	274	231	(32)	500
’22	93	157	98	254	602
’21	63	159	211	277	710
’20	78	(91)	261	350	599

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(122)	212	—	—	—
’25	6	88	141	338	573
’24	156	259	117	168	700
’23	(4)	237	191	(71)	353
’22	74	133	74	225	506
’21	49	141	194	247	631
’20	55	(98)	254	339	550

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.92	0.82	—	—	—
’25	0.88	0.70	0.84	0.85	3.27
’24	0.72	0.80	0.78	0.74	3.05
’23	0.91	1.06	1.05	0.13	3.16
’22	1.30	1.16	1.09	0.34	3.91
’21	1.16	1.10	1.15	1.05	4.45
’20	0.91	(0.08)	0.99	1.00	2.82

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	55.94	51.20	49.07	56.58	41.85	60.70	64.75	60.01	63.67	60.56	Analyst estimates 2026–2028 Powerpack
	High	71.76	73.33	71.65	72.81	73.99	83.45	92.68	89.72	82.63	82.49
People
People	Employees	21,000	22,000	18,000	19,000	19,000	21,600	22,000	25,000	25,000	25,000
	Revenue/emp, $m	0.55	0.40	0.52	0.53	0.53	0.57	0.57	0.49	0.51	0.53
Income, $m
Income, $m	Revenue	11,572	8,883	9,418	9,986	10,119	12,401	12,647	12,339	12,673	13,184
	Gross margin, %	27.88	30.92	30.91	30.95	27.83	29.63	30.29	31.28	31.69	31.14
	EBT	756	630	537	680	500	831	721	542	513	533
	EBT margin, %	6.53	7.09	5.70	6.81	4.94	6.70	5.70	4.39	4.05	4.04
	Net income	556	459	562	719	420	660	566	436	398	419
	Depreciation	170	134	144	185	186	210	212	275	309	311
Per share, $
Per share, $	Revenue	71.59	56.66	61.69	67.56	71.01	88.52	92.95	94.47	99.95	109.13
	Earnings	3.14	2.59	3.51	4.70	2.83	4.51	3.95	3.18	3.07	3.29
	Cash flow	3.98	3.48	4.49	4.43	4.20	5.07	4.42	3.83	6.69	5.89
	Capex	(0.43)	(0.40)	(0.47)	(0.52)	(0.34)	(0.56)	(0.71)	(1.13)	(1.17)	(1.15)
	Free cash flow	3.54	3.08	4.02	3.91	3.86	4.50	3.72	2.70	5.52	4.74
	Book value	17.33	18.01	23.20	24.56	27.96	29.00	30.10	32.84	31.79	32.27
	Shares, m	162	157	153	148	143	140	136	131	127	121
Valuation, ×
Valuation, ×	P/E	19.54	21.81	17.49	14.11	23.63	17.23	20.25	23.76	22.54	22.90
	P/S	0.85	0.99	1.00	0.99	0.94	0.88	0.86	0.80	0.69	0.69
	P/B	3.53	3.11	2.65	2.72	2.39	2.67	2.64	2.30	2.18	2.34
	EV/Sales	0.92	1.07	1.10	1.05	0.96	0.93	0.93	0.96	0.83	0.86
	EV/FCF	18.52	19.74	16.84	18.15	17.70	18.33	23.24	33.39	15.05	19.75
Cash, $m
Cash, $m	Operating cash flow	643	546	685	654	599	710	602	500	848	712
	Capex	(70)	(62)	(71)	(76)	(49)	(79)	(96)	(147)	(148)	(139)
	Free cash flow	572	483	613	578	550	631	506	353	700	573
Balance, $m
Balance, $m	Working capital	1,022	1,257	956	1,188	1,508	1,537	1,764	1,805	1,180	1,236
	Total debt	781	924	989	733	626	822	1,046	2,087	1,886	2,343
	Net debt	719	750	932	627	204	704	929	1,916	1,764	2,187
	Shareholders’ equity	2,801	2,824	3,542	3,630	3,984	4,063	4,095	4,289	4,031	3,899
Returns, %
Returns, %	ROA	7.64	5.56	6.55	8.88	5.41	7.76	6.30	4.34	3.75	3.71
	ROIC	13.70	11.71	8.39	10.55	7.98	11.17	9.29	6.19	6.70	6.71
	ROE	17.82	14.45	16.84	19.37	10.61	15.68	13.19	9.92	9.38	10.04

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
MCK McKesson Corporation	$116.4B	26.8×	18.3×	+7.72% (above 0%: growing)	−17.68% (below 0%: shrinking)	+66.40% (above 0%: growing)	3.50%	1.25%	Compare
COR Cencora, Inc.	$65.2B	25.2×	14.5×	+5.07% (above 0%: growing)	+11.27% (above 0%: growing)	+3,385.25% (above 0%: growing)	4.26%	1.32%	Compare
CAH Cardinal Health, Inc.	$58.8B	35.0×	23.3×	+5.84% (above 0%: growing)	+68.32% (above 0%: growing)	+10.87% (above 0%: growing)	4.02%	1.14%	Compare
HSIC Henry Schein, Inc.	$9.7B	25.0×	18.5×	+6.73% (above 0%: growing)	+16.90% (above 0%: growing)	+140.91% (above 0%: growing)	31.84%	4.95%
AHG Akso Health Group Sponsored ADR	$1.2B	— (loss-making)	— (loss-making)	+263.89% (above 0%: growing)	n/m	−12,975.04% (below 0%: shrinking)	0.00%	0.00%	Compare
FOCL FocalTherics	$154.8M	— (loss-making)	— (loss-making)	+38.85% (above 0%: growing)	n/m	+21.49% (above 0%: growing)	55.59%	(60.83%)	Compare
COSM Cosmos Health Inc.	$33.9M	— (loss-making)	25.1×	+28.76% (above 0%: growing)	n/m	+9.39% (above 0%: growing)	7.96%	(15.41%)	Compare
ACH Accendra Health, Inc.	$20.1M	— (loss-making)	— (loss-making)	−10.07% (below 0%: shrinking)	n/m	−1,624.82% (below 0%: shrinking)	42.95%	(5.73%)	Compare
HKPD Cellyan Biotechnology Co., Ltd	$17.1M	—	—	—	—	−90.45% (below 0%: shrinking)	—	—	Compare
Median of peers	$652.4M	26.8×	20.8×	+7.72%	+11.27%	+10.13%	4.26%	0.00%

All 11 Medical Distribution stocks →

Henry Schein, Inc. (HSIC) key facts

Strength: Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.
Strength: Net income was $419.0 million, or $3.29 per share (basic), a net margin of 3.02%.
Henry Schein, Inc. (HSIC) is a Medical Distribution company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, HSIC traded at $86.38, a market capitalization of $9.7 billion.
At that price the stock trades at 25.0× trailing-twelve-month earnings and 0.7× sales; its P/E is higher than 90% of its own readings over the past ten years.
Return on equity was 10.0% and debt-to-equity 0.64.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 2.66 (grey zone) for fiscal 2025.